According to LEO MCKINSTRY, our future is bright thanks to Britain’s scientific innovation.
As SUMMER draws to a close, it’s all too tempting to feel down about the status of the world. The news is grim in so many areas, from the Covid pandemic to climate change predictions.
However, it is necessary to have a sense of perspective. We are not in the midst of the apocalypse. On the contrary, life on this planet is safer, richer, healthier, cleaner, and freer than it has ever been in the twenty-first century. Growing wealth has been matched by the growth of democracy around the world. Life expectancy has increased while child mortality has decreased. Humanity’s ever-deepening understanding of science and technology has been a significant driver of this progress. Our incredible potential for innovation has aided in the eradication of sickness, the creation of riches, the development of new kinds of energy, the improvement of living standards, and the expansion of infrastructure.
90% of the world’s population now has access to clean water, and 1.2 billion people have acquired access to electricity since the turn of the century, thanks to technological advancement.
This week, we saw yet another powerful demonstration of science’s ability to enhance our lives. The NHS is poised to bring out a medicine called inclisiran, which might save 30,000 lives and prevent 55,000 heart attacks, as this newspaper reported yesterday.
This innovative injection, which will be marketed as Leqvio and manufactured by the pharmaceutical giant Novartis, will be given to about 300,000 patients twice a year. Given that heart attacks and strokes are the leading causes of mortality in the United Kingdom, it’s no surprise that health officials have dubbed this medical innovation “a game changer.”
Indeed, inclisiran’s global trials were presided over by Professor Kausik Ray of Imperial College, who described the rollout as “perhaps the most exciting thing I have been associated with in over 20 years of research.”
This positive achievement was accompanied by more good news on the medical front, as GlaxoSmithKline revealed that it will begin phase three trials of a new Covid-19 vaccine, which might transform supplies to the impoverished world, in collaboration with a South Korean business.
The government’s own armory against the disease is already well-stocked, thanks to the government’s forethought in launching our own program, our regulator’s quick approval of life-saving vaccines, and the. “Brinkwire News in Condensed Form.”